XORTX Therapeutics XRTX
NASDAQ XRTX
$1.70 0.00 (-0.28%)
As of: Sep 30, 2026 · 10:23 AM EDT

XORTX Therapeutics (XRTX) Market Capitalization (2021 - 2026)

Updated

XORTX Therapeutics' Market Capitalization was $2.05 million in the quarter ended Jun 30, 2026, down 21.2% from $2.61 million a year earlier but up 5.9% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Market Capitalization (2021 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Market Capitalization at XORTX Therapeutics came in at $2.66 million, down 18.2% from the prior year.

  • Market Capitalization has now declined for four consecutive years, with a four-year compound annual growth rate of -65.2% (years ended Dec 2021 to Dec 2025).
  • In earlier years, Market Capitalization was $3.25 million in the year ended Dec 31, 2024 (-29.6%), $4.62 million in the year ended Dec 31, 2023 (-95.8%), $109.3 million in the year ended Dec 31, 2022 (-39.8%) and $181.69 million in the year ended Dec 31, 2021.
  • Quarterly Market Capitalization has moved between $1.94 million (the quarter ended Mar 31, 2026) and $297.78 million (the quarter ended Sep 30, 2021) over five years.
  • Compared with a year earlier, Market Capitalization has declined for 16 straight quarters, with an average decline of 39.7% over the last eight quarters.
  • Over the past five years, the year-over-year decline in Market Capitalization ranged from 18.2% (the quarter ended Dec 31, 2025) to 96.0% (the quarter ended Sep 30, 2024).
  • Per Business Quant data, XRTX's Market Capitalization in the three quarters before the quarter ended Jun 30, 2026 was $1.94 million (quarter ended Mar 31, 2026), $2.66 million (quarter ended Dec 31, 2025) and $2.33 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 XORTX Therapeutics 1.62 Mn -1.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.05 Mn
Mar 31, 2026 1.94 Mn
Dec 31, 2025 2.66 Mn
Sep 30, 2025 2.33 Mn
Jun 30, 2025 2.61 Mn
Mar 31, 2025 2.76 Mn
Dec 31, 2024 3.25 Mn
Sep 30, 2024 3.28 Mn
Jun 30, 2024 3.80 Mn
Mar 31, 2024 7.40 Mn
Dec 31, 2023 4.62 Mn
Sep 30, 2023 81.16 Mn
Jun 30, 2023 87.80 Mn
Mar 31, 2023 62.90 Mn
Dec 31, 2022 109.30 Mn
Sep 30, 2022 107.24 Mn
Jun 30, 2022 124.97 Mn
Mar 31, 2022 172.82 Mn
Dec 31, 2021 181.69 Mn
Sep 30, 2021 297.78 Mn
API Access

XORTX Therapeutics Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=XRTX&period=max&api_key=YOUR_API_KEY